Your browser doesn't support javascript.
loading
Efficient High-Throughput Screening by Endoplasmic Reticulum Ca2+ Measurement to Identify Inhibitors of Ryanodine Receptor Ca2+-Release Channels.
Murayama, Takashi; Kurebayashi, Nagomi; Ishigami-Yuasa, Mari; Mori, Shuichi; Suzuki, Yukina; Akima, Ryunosuke; Ogawa, Haruo; Suzuki, Junji; Kanemaru, Kazunori; Oyamada, Hideto; Kiuchi, Yuji; Iino, Masamitsu; Kagechika, Hiroyuki; Sakurai, Takashi.
Afiliação
  • Murayama T; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Kurebayashi N; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Ishigami-Yuasa M; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Mori S; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Suzuki Y; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Akima R; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Ogawa H; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Suzuki J; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Kanemaru K; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Oyamada H; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Kiuchi Y; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Iino M; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Kagechika H; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
  • Sakurai T; Department of Pharmacology, Juntendo University School of Medicine, Tokyo, Japan (T.M., N.K., Y.S., R.A., T.S.); Institute of Biomaterials and Bioengineering, Tokyo Medical and Dental University, Tokyo, Japan (M.I.-Y., S.M., H.K.); Institute for Quantitative Biosciences (H.Og.) and Department of Cel
Mol Pharmacol ; 94(1): 722-730, 2018 07.
Article em En | MEDLINE | ID: mdl-29674523

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bloqueadores dos Canais de Cálcio / Cálcio / Canal de Liberação de Cálcio do Receptor de Rianodina / Retículo Endoplasmático Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Bloqueadores dos Canais de Cálcio / Cálcio / Canal de Liberação de Cálcio do Receptor de Rianodina / Retículo Endoplasmático Tipo de estudo: Diagnostic_studies / Prognostic_studies / Screening_studies Limite: Humans Idioma: En Ano de publicação: 2018 Tipo de documento: Article